Detalhe da pesquisa
1.
Phase II Trial of Concurrent Nivolumab and Radiation Therapy for Muscle-Invasive Bladder Cancer of Older or Chemotherapy-Ineligible Patients.
Int J Radiat Oncol Biol Phys
; 118(5): 1472-1480, 2024 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37981040
2.
Race-related Differences in Sipuleucel-T Response Among Men with Metastatic Castrate-Resistant Prostate Cancer.
Cancer Res Commun
; 2024 Jun 10.
Artigo
Inglês
| MEDLINE | ID: mdl-38856749
3.
Phase II Trial of Pembrolizumab and Anti-CD3 x Anti-HER2 Bispecific Antibody-Armed Activated T Cells in Metastatic Castration-Resistant Prostate Cancer.
Clin Cancer Res
; 29(1): 122-133, 2023 01 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36255393
4.
Safety and efficacy of molecularly targeted agents in patients with metastatic kidney cancer with renal dysfunction.
Anticancer Drugs
; 22(8): 794-800, 2011 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-21799472
5.
Clinical Efficacy of Enzalutamide vs Bicalutamide Combined With Androgen Deprivation Therapy in Men With Metastatic Hormone-Sensitive Prostate Cancer: A Randomized Clinical Trial.
JAMA Netw Open
; 4(1): e2034633, 2021 01 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33496795
6.
Adrenal Metastases as Sanctuary Sites in Advanced Renal Cancer.
J Kidney Cancer VHL
; 7(4): 1-7, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-33178553
7.
Phase II trial of capecitabine and weekly docetaxel for metastatic castrate resistant prostate cancer.
J Urol
; 182(1): 317-23, 2009 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-19447430
8.
Neutrophil lymphocyte ratio and duration of prior anti-angiogenic therapy as biomarkers in metastatic RCC receiving immune checkpoint inhibitor therapy.
J Immunother Cancer
; 5(1): 82, 2017 10 17.
Artigo
Inglês
| MEDLINE | ID: mdl-29041991
9.
A Pilot Trial Evaluating Zoledronic Acid Induced Changes in [18F]FMAU-Positron Emission Tomography Imaging of Bone Metastases in Prostate Cancer.
Mol Imaging Biol
; 19(6): 810-816, 2017 12.
Artigo
Inglês
| MEDLINE | ID: mdl-28289967
10.
Phase II Trial of Carboplatin, Everolimus, and Prednisone in Metastatic Castration-resistant Prostate Cancer Pretreated With Docetaxel Chemotherapy: A Prostate Cancer Clinical Trial Consortium Study.
Urology
; 86(6): 1206-11, 2015 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-26375845
11.
The effect of targeted therapy on overall survival in advanced renal cancer: a study of the national surveillance epidemiology and end results registry database.
Clin Genitourin Cancer
; 12(2): 124-9, 2014 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-24225251
12.
Phase II trial of bevacizumab and satraplatin in docetaxel-pretreated metastatic castrate-resistant prostate cancer.
Urol Oncol
; 32(1): 31.e25-33, 2014 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-23433892
13.
Management of adverse events associated with the use of everolimus in patients with advanced renal cell carcinoma.
Eur J Cancer
; 47(9): 1287-98, 2011 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-21481584
14.
Phase II trial of capecitabine and weekly docetaxel in metastatic renal cell carcinoma.
Urology
; 72(4): 898-902, 2008 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-18692873